The largest database of trusted experimental protocols

Cobas integra reagents

Manufactured by Roche
Sourced in Switzerland, Poland

The Cobas Integra reagents are a series of analytical reagents designed for use with Roche's Cobas Integra clinical chemistry analyzers. The reagents are used to perform various tests and measurements on patient samples, supporting the diagnostic process. The core function of the Cobas Integra reagents is to provide the necessary chemicals and compounds required for the analyzers to conduct these tests accurately and reliably.

Automatically generated - may contain errors

2 protocols using cobas integra reagents

1

Comprehensive Baseline Data Analysis for Multiple Myeloma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Baseline demographic and clinical data were retrieved electronically from the medical records of the general hospital registry and reviewed retrospectively. For MM patients with multiple admissions, only the first set of observation data was used, thus preserving the assumption of independence of observations.
The following indicators were evaluated: 1) demographic characteristics, including age, sex, and underlying disease (hypertension and diabetes); 2) laboratory data, including hemoglobin, serum calcium, serum creatinine, albumin, globulin, serum/urine light chain protein, lactate dehydrogenase (LDH), and beta-2 microglobulin; 3) anti-myeloma therapy regimen; 4) duration of follow-up; 5) serum creatinine at the last follow-up evaluation, time of death, or dialysis; 6) serum calcium and albumin levels (Cobas Integra reagents; Roche Diagnostics, Switzerland).
Albumin-adjusted serum calcium was calculated using the following formula: serum albumin-corrected calcium (mg/dL) = total calcium (mg/dL) + 0.8 × [4 - albumin (g/dL)] [18 (link)–20 (link)].
+ Open protocol
+ Expand
2

Comprehensive Assessment of Cardiometabolic Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The blood concentration of HbA1C was determined using a turbidimetric immunoinhibition method. The concentrations of triglycerides (TG), total cholesterol, high-density and low-density lipoprotein cholesterol fractions (HDL, LDL) were assessed by standard enzymatic-colorimetric methods. The laboratory tests were conducted at baseline and at week 12 using the Roche device and Cobas Integra Reagents (Roche Diagnostics, Warszawa, Poland). Participants’ blood pressure and the cardiac hemodynamic parameters (the left ventricular ejection fraction (LVEF) and the left ventricular end-systolic and end-diastolic dimensions (LVEDD, LVESD)) were measured by one- and two-dimensional echocardiography with the Vivid 7 ultrasound scanner (General Electric, Waukesha, WI, USA). Average daily systolic and diastolic blood pressures (BPs, BPd) were calculated after 24-h ambulatory blood pressure monitoring (24-h ABPM) with the Boso Tm 2430 device (Bosch and Sohn, Jungingen, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!